What Results and Adoption Has Abridge Reported?
Updated
Abridge reports large-scale adoption and substantial clinician workload reductions, but every figure below is vendor-reported and should be verified independently before you treat it as a purchasing input. The headline claims are 100M+ conversations powered each year, use by 300+ health systems, a 78% reduction in cognitive load, and an 83% reduction in note-writing effort. These are useful as a starting point for due diligence, not as settled evidence.
Reported Adoption
| Metric | Reported figure |
|---|---|
| Conversations powered each year | 100M+ |
| Health systems using Abridge | 300+ |
| Clinicians (one cited deployment) | 9,400+ across 40+ specialties |
| Patients served (one cited program) | 500K+ across 60+ centers, 28 languages |
| User retention (one cited program) | 95% across 22 pediatric specialties |
The page also names enterprise deployments at Kaiser Permanente (described as the largest generative AI project in healthcare through Abridge), Johns Hopkins Medicine, Duke Health, and Yale New Haven Health. Named deployments are the easiest claims to check: ask each organization's press office or your peer contacts whether the rollout is live, at what scale, and in which specialties.
Reported Outcome Metrics
The vendor cites several distinct categories of results. Read them as separate claims, because they come from different customer programs and are not a single controlled study.
- Cognitive load: 78% reduction, cited alongside a program covering 800+ providers saving 30 minutes per day on documentation.
- Note-writing effort: 83% reduction in one program; 86% reduction at Reid Health, where patients also reported clinicians were more present during visits.
- Burnout: 55% decrease, cited twice for a program covering 500K+ patients, 60+ centers, and 28 languages.
- Documentation effort: 86% reduction at Reid Health.
- Throughput and revenue: 43% increase in ability to accommodate urgent patients at WVU Medicine; 14% increase in wRVUs at Riverside Health, tied to more precise accounting of care and additional clarity in notes.
- Patient access: listed as an impact category without a single consolidated number on the page.
What these numbers do and do not tell you
A percentage reduction in note-writing effort is a self-reported or workflow-derived measure, not an audited clinical or financial outcome. The wRVU and urgent-patient-access figures are closer to operational results, but they are single-customer case examples. Before relying on any of them, ask for the measurement method, the baseline period, and whether the result held after the initial pilot.
How to Verify Before You Decide
Use the vendor's own claims as a checklist for reference calls rather than as conclusions.
- Match your context. Ask for a customer in your specialty mix and organization size. A 22-specialty pediatric program and a large integrated system are different proofs.
- Request the measurement definition. For each metric you care about (documentation time, burnout, wRVUs), ask how it was calculated and over what period.
- Talk to a named deployment. Kaiser Permanente, Johns Hopkins, Duke Health, and Yale New Haven Health are publicly referenced; use peer channels to confirm scope and clinician sentiment.
- Run a bounded pilot. Define baseline documentation minutes per clinician per day and note-correction rates before go-live, then compare after a fixed period.
- Check the workflow fit. The page describes pre-visit preparation, in-visit documentation, and downstream handling after the visit; confirm each stage works with your EHR and coding process.
Bottom Line
Abridge presents a credible adoption story — 300+ health systems, 100M+ annual conversations, and named enterprise customers — plus large reported reductions in documentation burden. Treat the percentages as vendor-reported and validate them against a pilot in your own specialty and workflow before committing.